Key result
Good compliance with antihypertensive therapy was achieved in 60% of patients, with the highest rates observed among those on monotherapy (74%) and single daily dosing regimens (70%).
Why the study?
Does dosing frequency and pill burden affect self-reported compliance in hypertensive patients?
Cross-Sectional (n=100)
No
Does dosing frequency and pill burden affect self-reported compliance in hypertensive patients?
Monotherapy and single daily dosing regimens are associated with better self-reported compliance among hypertensive patients.
Monotherapy or once-daily dosing may aid compliance; cross-sectional data leave causal effects and practice change open.
BACKGROUND: Hypertension contributes significantly to cardiovascular morbidity and mortality. Adequate blood pressure control would therefore reduce cardiovascular morbidity and mortality, however adequate blood pressure control requires good treatment compliance. METHODS: One hundred consecutive patients aged 30-79 years attending the cardiac clinic of the medical out-patients clinic of the University of Port Harcourt Teaching Hospital were directly questioned about compliance with their antihypertensive drugs and results entered into the questionnaire designed for the study. RESULTS: Compliance was good in sixty percent (60%) of respondents, fair in twenty nine percent (29%) and poor in eleven percent (11%). Compliance was also found to be good in sixty-seven percent (67%) of patients with tertiary education, good in forty one percent (41%) of those with primary education. Compliance was good in seventy four percent (74%) of those taking one drug, good in only thirty three percent (33%) of those taking four drugs. Patients taking single daily dose drugs had good compliance in seventy percent (70%), twice daily dosing had good compliance in fifty five percent (55%) and among those taking thrice daily dosage, compliance was good in only seventeen percent (17%). CONCLUSION: The study shows that good compliance with anti-hypertensive therapy is best achieved with monotherapy given as single dosage. It also shows the role of education in the level of compliance.
No takes yet. Share an insight, caveat, or question.
Akpa et al. (2006) conducted a cross-sectional in Hypertension (n=100). Antihypertensive drugs was evaluated on Compliance with antihypertensive drugs. Good compliance with antihypertensive therapy was achieved in 60% of patients, with the highest rates observed among those on monotherapy (74%) and single daily dosing regimens (70%).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: